CAS 176022-59-6: roxifiban
Description:Roxifiban is a synthetic chemical compound classified as a glycoprotein IIb/IIIa receptor antagonist, primarily used in the context of cardiovascular medicine. It functions by inhibiting platelet aggregation, thereby reducing the risk of thrombus formation in patients with acute coronary syndromes. Roxifiban is characterized by its ability to selectively bind to the glycoprotein IIb/IIIa receptor on platelets, which plays a crucial role in the final common pathway of platelet activation and aggregation. The compound is typically administered intravenously and has been investigated for its efficacy in various clinical settings, including percutaneous coronary interventions. Its pharmacokinetic profile includes rapid onset of action and a relatively short half-life, necessitating careful monitoring and dosage adjustments in clinical use. As with many antiplatelet agents, potential side effects may include bleeding complications, which require careful patient selection and management. Overall, roxifiban represents a significant advancement in antithrombotic therapy, contributing to improved outcomes in patients with cardiovascular diseases.
Formula:C23H33N5O8
InChI:InChI=1/C21H29N5O6.C2H4O2/c1-3-4-9-31-21(29)25-17(20(28)30-2)12-24-18(27)11-15-10-16(26-32-15)13-5-7-14(8-6-13)19(22)23;1-2(3)4/h5-8,15,17H,3-4,9-12H2,1-2H3,(H3,22,23)(H,24,27)(H,25,29);1H3,(H,3,4)/t15-,17+;/m1./s1
- Synonyms:
- DMP 754
- (2S)-3-(2-((5R)-3-(p-Amidinophenyl)-2-isoxazolin-5-yl)acetamido)-2-(carboxyamino)propionic acid, 2-butyl methyl ester, monoacetate
- Roxifiban acetate
- L-Alanine, 3-((((5R)-3-(4-(aminoiminomethyl)phenyl)-4,5-dihydro-5-isoxazolyl)acetyl)amino)-N-(butoxycarbonyl)-, methyl ester, monoacetate
- methyl N-(butoxycarbonyl)-3-({[(5R)-3-(4-carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]acetyl}amino)-L-alaninate acetate (1:1)
- L-Alanine, 3-(((3-(4-(aminoiminomethyl)phenyl)-4,5-dihydro-5-isoxazolyl)acetyl)amino)-N-(butoxycarbonyl)-, methyl ester, (R)-, monoacetate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Roxifiban acetate REF: 54-BUP06817CAS: 176022-59-6 | ≥98% | 2,469.00 €~7,696.00 € | Mon 05 May 25 |
![]() | Roxifiban acetate REF: TM-T24733CAS: 176022-59-6 | 99.33% - 99.56% | 492.00 €~2,945.00 € | Tue 08 Jul 25 |

Ref: 54-BUP06817
25mg | 2,469.00 € | ||
50mg | 3,061.00 € | ||
100mg | 3,986.00 € | ||
200mg | 4,927.00 € | ||
500mg | 7,696.00 € |

Roxifiban acetate
Ref: TM-T24733
1mg | 492.00 € | ||
5mg | 1,111.00 € | ||
25mg | 1,825.00 € | ||
50mg | 2,262.00 € | ||
100mg | 2,945.00 € |